Metimepip
Изглед
Nazivi | |
---|---|
IUPAC naziv
4-(1H-imidazol-4-ilmetil)-1-metilpiperidin
| |
Identifikacija | |
3D model (Jmol)
|
|
| |
Svojstva | |
C10H17N3 | |
Molarna masa | 179,262 g/mol |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
verifikuj (šta je ?) | |
Reference infokutije | |
Metimepip je histaminski agonist koji je visoko selektivan za H3 receptor. On je N-metil derivat imepipa.[3]
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Kitbunnadaj R; Hashimoto T; Poli E; et al. (2005). „N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist”. Journal of Medicinal Chemistry. 48 (6): 2100—7. PMID 15771452. doi:10.1021/jm049475h.